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patient years follow-up, that high pre-dialysis blood pres- tried to collect PTH levels. However, the data were unus-
able, largely reflecting the methodological heterogeneitysure strongly (and independently) pre-dates progressive
left ventricular enlargement [1]. Cohort studies have in measuring PTH in the 1980s.
Dr Toz and colleagues are quite right in pointing outclear advantages over cross-sectional designs, not the
least of which is the inability to tell the chicken from that this is not a natural history study in the strict sense
of the term, because intervention took place throughoutthe egg. It is hard to tell from an observational study
like this why, for example, an ACE inhibitor is used the study. We did not intend to engender fatalism in this
study. We wished to suggest that a pro-active approachin one patient, and a calcium blocker in another. As
exemplified in the recent calcium channel blocker de- may be superior with respect to known modifiable risk
factors. Clearly, we are very far from knowing all thebate, randomized controlled trials are a much better
vehicle to address this type of issue. The point is well modifiable risk factors for long-term LV enlargement.
We fully endorse the sentiment that intervention trials,taken, however. It is true that progressive LV enlarge-
ment slowed down beyond the first year. However, it many of them, are needed to resolve the complicated
problems of cardiovascular morbidity in dialysis patients.did not stop. We agree that blood pressure levels are
relatively good. Several studies, published long after this
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study began, show that hemoglobin levels of 8.6 g/dl Division of Nephrology, Memorial University of Newfoundland,
are sub-optimal, and likely to promote LV enlargement. The Health Sciences Center, St. John’s, Newfoundland, Canada
Four facts remain from our study. First, progressive LV
enlargement was strongly associated with anemia in the REFERENCES
first year. Second, progressive LV enlargement contin- 1. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC,
ued to occur after year 1. Third, hemoglobin levels, if Barre PE: Impact of hypertension on cardiomyopathy, morbidity
and mortality in end-stage renal disease. Kidney Int 49:1379–1385,anything, were worse in years 2 and 3 than in year 1.
1996Fourth, the LV enlargement seen after one year was
not associated with the observed hemoglobin levels. The
contrast between a strong early association and an absent High serum IgE levelslater association is certainly striking; ours is one of many
possible interpretations. We agree wholeheartedly that are associated withcontrol of currently known risk factors needs to be opti-
mized at all times. However, what constitutes optimal selective proteinuriatreatment for an individual patient may change over
time. Therein lies a major challenge! in glomerulonephritisDr Strozecki and colleagues also make several reason-
able points. We fully admit that this is a small, highly- To the Editor: We were interested to read the paper
selected subgroup. However, it is self-selected, demon- by Ehara and Shigematsu on mast cells in IgA nephritis
strably, in response to the following pressures: staying [1] and wish to report our data supporting a potential
alive, and not receiving a transplant for a long period role of type I hypersensitivity in glomerulonephritis
of time. This was a study of differences in time in left (GN). The mechanisms ultimately resulting in protein-
ventricular characteristics. One of the advantages of a uria in GN are now better understood. An autoimmune
repeated measures design like this is that it minimizes basis with genetic susceptibility, leading to glomerular
the impact of known fixed characteristics (like age, diabe- injury by non-inflammatory and inflammatory mecha-
tes, sex and original kidney disease) and unknown fixed nisms and triggered by an antibody-antigen interaction,
characteristics. It is much more likely that a change in is likely. Type I hypersensitivity in GN, however, has
LV morphology or function would cause heart failure not been extensively studied, although the association of
than vice versa, so that enumerating who did and did atopy in minimal change disease and nephrotic syndrome
not develop heart failure is somewhat of a side issue due to allergens (food and insect stings) and infections
when looking at temporal trends in LV parameters. We (parasites and others) is well recognized. IgE typically
agree that peritoneal dialysis and hemodialysis patients binds to mast cells and basophils but also to low-affinity
need to be analyzed separately. One of the reasons for receptors on inflammatory cells and platelets, with the
using data from both peritoneal dialysis and hemodialy- release of inflammatory mediators and chemotactic fac-
sis patients was to compare the therapies with regard to tors that have been incriminated in GN. Evidence sup-
LV parameters. We have checked things separately and porting the role of type I hypersensitivity in the patho-
the associations are similar. This is not too surprising genesis of GN comes from reports of high levels of serum
with such small sample sizes. Figure 1 illustrates this
for hemoglobin levels. Alkaline phosphatase levels were
unassociated with progression in this set of patients. We  1999 by the International Society of Nephrology
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IgE (sIgE), its deposition in the kidney, IgE autoantibod-
ies (IgE ANA in lupus nephritis), basophil sensitization
[2, 3], and now the elegant confirmation by Ehara and
Shigematsu of renal mast cells in IgA nephritis.
The glomerular filtration barrier is charge- and size-
selective with selective proteinuria, which is not histol-
ogy-specific and predicts steroid response [4], being
considered the result of loss of anionic sites. Our observa-
tions suggested that sIgE levels influence treatment re-
sponse, which, along with the severity of GN, has been
alluded to in previous studies. We therefore investigated
sIgE levels in patients with nephrotic range proteinuria
and assessed whether there was an association with the
pattern of protein selectivity. Consecutive patients with
nephrotic range proteinuria (.3 g/day) prior to biopsy
and relapsing patients with histologically proven GN
Fig. 1. Boxplot of serum IgE levels for patients with selective and non-were studied. The serum creatinine and 24-hour urine
selective proteinuria, showing the median value and interquartile range.
protein excretion (TUP) were measured. Serum IgE lev- *, P 5 0.015.
els were measured by immunofluorometry and the selec-
tivity index (SI) by standard methods as IgG/transferrin
clearance. Selective proteinuria was defined as SI ,0.2
interquartile ranges being 236–1410 IU/ml and 16–115and non-selective as .0.2. The results were analyzed
IU/ml respectively (Fig. 1).by Wilcoxan rank sum and Spearman rank correlation
This study confirms previous reports of raised sIgEcoefficient tests.
levels in GN. The correlation between sIgE and SI, withThirty-one patients were studied, mean age 33 years
(range, 17–55), 15 males and 16 females. No patient gave significantly higher levels associated with selective pro-
a history of allergy or had evidence of active infection. teinuria among patients with nephrotic range protein-
The histology indicated IgA nephritis (11), lupus nephri- uria, has not been documented previously. The associa-
tis (9), minimal change disease (3), diffuse mesangiopro- tion may be of clinical use, although it is not yet known
liferative (IF-negative) GN (3), focal segmental glomeru- whether high sIgE levels will predict treatment response.
losclerosis (FSGS, 3) and membranous GN (2). The Earlier studies have shown no correlation between serum
median serum creatinine was 93 mmol/l (range, 64–192), and urinary IgE levels, IgE being only locally secreted
TUP median 4.8 g/day (range, 3–10.8) and selectivity and partially filtered at the glomerulus, and it is therefore
index median 0.22 (range, 0.04–0.44). Selective protein- important to consider a possible mechanism of IgE-medi-
uria was seen in 14 patients whose median SI was 0.12 ated selective proteinuria in GN. Loss of the anionic
(range, 0–0.18), while in the remaining 17 patients the charge on the glomerular filtration barrier, which is cre-
median SI was 0.3 (range, 0.21–0.44). Although patients ated by the sulphate groups of heparan sulphate (and
with IgA nephritis had predominantly non-selective pro- sialoproteins), may result from enzymatic degradation
teinuria (8/11) and all three patients with FSGS selective of these molecules. Intriguingly, it has recently been re-
proteinuria, the histological types were otherwise not ported that mast cells express heparanase capable of
distinguished by the SI. There was no difference between degrading heparan sulphate in a subendothelial extracel-
the ages, serum creatinine or TUP between those with lular matrix [5]. This provides a possible mechanism for
selective and non-selective proteinuria. The median sIgE the association between high sIgE and selective protein-
level for all the patients was 112 IU/ml (range, 5–6940), uria reported here. More detailed investigation into a
with no correlation to the serum creatinine or TUP. The potential role of IgE, mast cells and type I hypersensitiv-
sIgE levels showed inverse correlation with the SI (r 5 ity in the pathogenesis of GN is warranted.
0.33, P , 0.05), the median values and ranges for patients
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